ARVIDAL (Class 5)

The trademark application number 4927842 is currently marked as "Protection Granted" in the official trademark registry.

The trademark application number 4927842 is owned by PVP LABS PTE. LTD..

Trademark application number 4927842 is filed under Class 5, which relates to the specified goods and services.

Yes, trademark application number 4927842 was published in Journal No. 2021.

Trademark application number 4927842 relates to "Pharmaceutical preparations; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses, namely by intravenous, intramuscular, oral, sublingual, buccal, nasal, topical administration and/or administered by inhalation, by spraying or by nebulisation in patients; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viruses, seasonal and pandemic influenza A and B viruses, seasonal coronaviruses (Alpha-, Beta-, Gamma- and Deltacoronaviruses), severe acute respiratory syndrome (SARS-CoV) coronaviruses and Middle East respiratory syndrome (MERS) coronavirus, adenoviruses, respiratory syncytial viruses, parainfluenza viruses, rhinoviruses, human metapneumoviruses, bocaviruses, and infections of combined etiology (multiple viral infections); pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of acute respiratory infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of tissue lesions in the lungs caused by severe pulmonary infectious diseases; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of complications arising from or caused by viral infections; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of acute respiratory infections, acute respiratory viral infections of unknown origins and complications arising from or caused by viral infections.".